Novartis buying BMY's North American OTC business

Bristol-Myers (BMY) agreed to sell its U.S. and Canadian consumer medicines business to Novartis (NVS; SWX:NOVN) for $660 million in cash. The deal is expected to close this quarter. BMY announced its...